Search

everythinglearnresearchcommunity

for

Search:↓

During the COVID-19 pandemic, some skin conditions became more common while others decreased.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

Post-earthquake, skin issues like dermatitis and infections were common due to trauma, disinfectants, and stress.

Hospitalizations for atopic dermatitis are more due to other health issues now, not the condition itself.

COVID-19 may cause temporary hair loss in some people.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

COVID-19 infection may trigger alopecia areata in some patients.

Men had worse COVID-19 outcomes than women in New York City.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document concludes that products like PRP and PRF show promise for tissue healing, but evidence of their effectiveness is inconsistent.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Accidentally eating a topical steroid may rarely cause acute generalized pustular psoriasis.

Hair loss and mental health issues like anxiety and insomnia affect each other, impacting quality of life.

People who had severe COVID-19 are more likely to experience hair loss.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Diabetic patients need tailored cosmetic treatments for skin aging, with new therapies showing promise.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.